Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo.

Cirrito JR, Yamada KA, Finn MB, Sloviter RS, Bales KR, May PC, Schoepp DD, Paul SM, Mennerick S, Holtzman DM.

Neuron. 2005 Dec 22;48(6):913-22.

2.

To think or not to think: synaptic activity and Abeta release.

Schroeder BE, Koo EH.

Neuron. 2005 Dec 22;48(6):873-5. Review.

3.

In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life.

Cirrito JR, May PC, O'Dell MA, Taylor JW, Parsadanian M, Cramer JW, Audia JE, Nissen JS, Bales KR, Paul SM, DeMattos RB, Holtzman DM.

J Neurosci. 2003 Oct 1;23(26):8844-53.

4.

Intracellular amyloid-beta in Alzheimer's disease.

LaFerla FM, Green KN, Oddo S.

Nat Rev Neurosci. 2007 Jul;8(7):499-509. Review.

PMID:
17551515
5.

Vascular endothelial growth factor (VEGF) affects processing of amyloid precursor protein and beta-amyloidogenesis in brain slice cultures derived from transgenic Tg2576 mouse brain.

Bürger S, Noack M, Kirazov LP, Kirazov EP, Naydenov CL, Kouznetsova E, Yafai Y, Schliebs R.

Int J Dev Neurosci. 2009 Oct;27(6):517-23. doi: 10.1016/j.ijdevneu.2009.06.011. Epub 2009 Jul 7.

PMID:
19589380
6.

Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses.

Abramov E, Dolev I, Fogel H, Ciccotosto GD, Ruff E, Slutsky I.

Nat Neurosci. 2009 Dec;12(12):1567-76. doi: 10.1038/nn.2433.

PMID:
19935655
7.
8.

Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-beta peptide in mouse brain.

Iwata N, Mizukami H, Shirotani K, Takaki Y, Muramatsu S, Lu B, Gerard NP, Gerard C, Ozawa K, Saido TC.

J Neurosci. 2004 Jan 28;24(4):991-8.

9.

A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition.

Flood DG, Lin YG, Lang DM, Trusko SP, Hirsch JD, Savage MJ, Scott RW, Howland DS.

Neurobiol Aging. 2009 Jul;30(7):1078-90. Epub 2007 Nov 28.

PMID:
18053619
10.

Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.

van Groen T, Kiliaan AJ, Kadish I.

Neurobiol Dis. 2006 Sep;23(3):653-62. Epub 2006 Jul 10.

PMID:
16829076
11.

Accelerated Abeta deposition in APPswe/PS1deltaE9 mice with hemizygous deletions of TTR (transthyretin).

Choi SH, Leight SN, Lee VM, Li T, Wong PC, Johnson JA, Saraiva MJ, Sisodia SS.

J Neurosci. 2007 Jun 27;27(26):7006-10.

12.

Beta-amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's disease.

Buttini M, Masliah E, Barbour R, Grajeda H, Motter R, Johnson-Wood K, Khan K, Seubert P, Freedman S, Schenk D, Games D.

J Neurosci. 2005 Oct 5;25(40):9096-101.

13.

GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice.

Tian J, Shi J, Zhang L, Yin J, Hu Q, Xu Y, Sheng S, Wang P, Ren Y, Wang R, Wang Y.

Curr Alzheimer Res. 2009 Apr;6(2):118-31.

PMID:
19355846
14.

Use of YFP to study amyloid-beta associated neurite alterations in live brain slices.

Brendza RP, Simmons K, Bales KR, Paul SM, Goldberg MP, Holtzman DM.

Neurobiol Aging. 2003 Dec;24(8):1071-7.

PMID:
14643378
15.

Alpha v integrins mediate beta-amyloid induced inhibition of long-term potentiation.

Wang Q, Klyubin I, Wright S, Griswold-Prenner I, Rowan MJ, Anwyl R.

Neurobiol Aging. 2008 Oct;29(10):1485-93. Epub 2007 Apr 17.

PMID:
17442458
16.

Intracellular and extracellular Abeta, a tale of two neuropathologies.

Cuello AC.

Brain Pathol. 2005 Jan;15(1):66-71. Review.

PMID:
15779238
17.

Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease.

Wati H, Kawarabayashi T, Matsubara E, Kasai A, Hirasawa T, Kubota T, Harigaya Y, Shoji M, Maeda S.

Brain Pathol. 2009 Jan;19(1):48-57. doi: 10.1111/j.1750-3639.2008.00166.x. Epub 2008 Apr 22.

PMID:
18429966
18.

Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulation.

Levi O, Dolev I, Belinson H, Michaelson DM.

J Neurochem. 2007 Nov;103(3):1031-40. Epub 2007 Jul 31.

19.

Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.

Pihlaja R, Koistinaho J, Malm T, Sikkilä H, Vainio S, Koistinaho M.

Glia. 2008 Jan 15;56(2):154-63.

PMID:
18004725
20.

Reducing amyloid plaque burden via ex vivo gene delivery of an Abeta-degrading protease: a novel therapeutic approach to Alzheimer disease.

Hemming ML, Patterson M, Reske-Nielsen C, Lin L, Isacson O, Selkoe DJ.

PLoS Med. 2007 Aug;4(8):e262.

Items per page

Supplemental Content

Write to the Help Desk